Riken Vitamin Co., Ltd. revised earnings guidance for the fiscal year ending March 31, 2024. For the year, the company expects net sales of JPY 90,600 million compared to Previous forecast of JPY 90,600 million, Operating profit of JPY 8,900 million compared to Previous forecast of JPY 7,700 million, Profit attributable to owners of parent of JPY 8,200 million compared to Previous forecast of JPY 6,600 million and earnings per share JPY 249.82 million compared to Previous forecast of JPY 201.09 million.